Enzyme Finance

The tokenized asset market has reached **$60 billion**, but approximately half of these assets are currently illiquid. Forbes describes this situation as "a waiting room" - assets exist on-chain but lack active trading or movement. **Key Points:** - $30B worth of tokenized assets are essentially dormant - This liquidity gap represents a significant infrastructure challenge - Early movers in tokenized fund operations are positioning themselves for future growth Enzyme Finance is developing [Onyx](http://enzyme.finance/products/onyx), a solution aimed at addressing this liquidity problem in the tokenized asset space. The platform targets fund managers and issuers looking to build operational infrastructure for tokenized assets. The situation highlights a common pattern in emerging markets: rapid asset growth outpacing the development of supporting infrastructure and liquidity mechanisms.

Onyx has introduced a cross-chain deposit feature that addresses a common pain point in vault infrastructure. The solution allows investors to deposit from any EVM chain into a single fund automatically. **Key features:** - Powered by [Chainlink CCIP](https://chain.link/cross-chain) - Managers can accept deposits and redemptions from any EVM chain - Maintains a single fund without requiring extra deployments - Eliminates reconciliation complexity Traditionally, vault infrastructures push cross-chain complexity onto fund managers. Onyx's approach centralizes this process, making multi-chain fund management more accessible. The feature is now live for managers looking to streamline their cross-chain operations.

**Credilabs** and **Turtle** have successfully implemented a **tokenized credit card receivables financing structure** on the Enzyme protocol as part of a Visa program. **Key Details:** - The implementation represents a real-world application of tokenized finance infrastructure - Built on Enzyme's asset management protocol on Ethereum - Part of Visa's broader blockchain and tokenization initiatives This deployment demonstrates how traditional financial instruments like credit card receivables can be brought on-chain through tokenization, enabling more efficient and transparent financing structures. Learn more at [enzyme.finance](http://enzyme.finance)

**The Reality of On-Chain Private Credit** Private credit represents a massive $6 trillion market that remains largely trapped in traditional spreadsheet-based systems. While many discuss the potential of bringing private credit on-chain, the practical implementation reveals specific challenges and opportunities. **Key Points:** - The infrastructure for on-chain private credit is moving from concept to actual deployment - Traditional private credit workflows rely heavily on manual processes and legacy systems - Blockchain rails offer potential improvements in transparency, settlement speed, and accessibility - Real-world implementation requires addressing regulatory frameworks and institutional adoption barriers The gap between theoretical discussions and practical applications of on-chain private credit highlights the ongoing evolution of decentralized finance infrastructure. As the market matures, understanding the actual mechanics becomes crucial for participants looking to navigate this emerging space.

**Enzyme has officially joined the Canton Foundation**, marking a significant step in expanding its infrastructure to regulated finance networks. **Key developments:** - Enzyme becomes a member of the Canton Foundation - Plans to bring **Onyx and Myso** natively to Canton Network in Q3 2026 - Aims to provide vault infrastructure for Canton's privacy-first, regulated finance rails Canton Network focuses on institutional-grade blockchain infrastructure with privacy features designed for regulated financial institutions. Enzyme's integration will bring its decentralized asset management capabilities to this environment. The move represents Enzyme's strategic expansion beyond Ethereum into networks serving traditional finance institutions seeking blockchain solutions.

**Enzyme Onyx** addresses different protocol needs across three key stages: - **Pre-TGE**: Early participation incentives to build community - **Post-TGE**: Strengthen Total Value Locked (TVL) after token launch - **Mature stage**: Manage liquidity across multiple assets including stablecoins and liquid staking tokens The platform provides structured, on-chain strategies that protocols can adopt when timing is right for their development phase. Each stage requires different tooling approaches, but most protocols eventually need comprehensive on-chain financial infrastructure. [Explore Onyx](https://enzyme.finance/products/onyx?utm_source=x&utm_medium=organic&utm_content=post)

**Multi-chain complexity solved**: As investment products expand across different blockchains, reporting becomes increasingly complex for asset managers. **Automated data sourcing**: Chainlink's CRE (Crypto Reporting Engine) automatically pulls and verifies NAV and performance data from: - On-chain sources - Centralized finance platforms - Traditional financial systems **Pain point addressed**: The solution eliminates manual reporting work that previously required tracking assets across multiple chains and platforms. **Verification built-in**: All data is automatically verified, reducing errors and ensuring accuracy for compliance and investor reporting.

Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers: - Native on-chain options strategies - Fully auditable transaction flows - Infrastructure designed for DAOs and institutions **Real-world implementation**: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure. This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies. *Learn more at* [Enzyme Finance](http://enzyme.finance/products/myso)

Major financial institutions are forecasting significant growth in tokenized assets: - Citi projects tokenized securities market could reach $45T by 2030 - WEF estimates 10% of global GDP could be blockchain-tokenized by 2027 - McKinsey reports shift from pilot to at-scale deployment Key trends expected in next cycle: - Shift to natively tokenized funds - Increased institutional adoption - Integration with DeFi infrastructure - Clearer regulatory framework Traditional finance faces challenges from outdated systems, while tokenized vehicles offer programmability and global accessibility. Enzyme Protocol is positioning to support this transition with native tokenization capabilities. [Learn more about tokenized funds](http://enzyme.finance/use-cases/tokenized-funds)

Real-world assets (RWAs) tokenized on blockchain have reached a significant milestone, surpassing $10B in Total Value Locked (TVL). This marks a crucial shift in how traditional assets are being brought on-chain. Key developments: - Over $18B in assets now tokenized (excluding stablecoins) - Infrastructure development becoming priority for operational use - Integration possibilities include RWA funds, ETPs, and indices Enzyme Protocol enables users to leverage these tokenized assets within investment strategies, marking a practical step toward mainstream RWA adoption. Learn more about tokenized asset infrastructure: [Chainlink's Guide](https://blog.chain.link/definitive-guide-to-tokenized-assets/)